Skandinaviska Enskilda Banken (SEB)’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-41,687
| Closed | -$493K | – | 937 |
|
2022
Q2 | $493K | Sell |
41,687
-4,875
| -10% | -$57.7K | ﹤0.01% | 812 |
|
2022
Q1 | $885K | Sell |
46,562
-15,302
| -25% | -$291K | 0.01% | 767 |
|
2021
Q4 | $1.72M | Hold |
61,864
| – | – | 0.01% | 678 |
|
2021
Q3 | $2.54M | Buy |
61,864
+20,730
| +50% | +$851K | 0.01% | 587 |
|
2021
Q2 | $2.33M | Buy |
41,134
+1,182
| +3% | +$67K | 0.01% | 623 |
|
2021
Q1 | $1.68M | Buy |
39,952
+22,523
| +129% | +$946K | 0.01% | 708 |
|
2020
Q4 | $1.22M | Sell |
17,429
-193
| -1% | -$13.5K | 0.01% | 773 |
|
2020
Q3 | $494K | Buy |
17,622
+17,224
| +4,328% | +$483K | ﹤0.01% | 826 |
|
2020
Q2 | $12K | Buy |
+398
| New | +$12K | ﹤0.01% | 1036 |
|